Clinical Trials in Detroit

Showing 1681-1700 of 19,719 trials

A Study of Ciltacabtagene Autoleucel and Talquetamab for the Treatment of Participants With High-Risk Multiple Myeloma

NCT06550895

The purpose of this study is to define the safety of Ciltacabtagene Autoleucel (Cilta-cel) and Talquetamab in participants with high-risk multiple myeloma (MM).

Multiple Myeloma

Janssen Research & Development, LLC11 participantsStarted Sep 2024

Iowa City, Iowa, United States • Louisville, Kentucky, United States • Detroit, Michigan, United States +6 more locations

RECRUITINGPhase 1< 1 mile

A Study to Investigate ANS014004 in Participants With Locally Advanced or Metastatic Solid Tumors

NCT06307795

This is a Phase 1, first-in-human, open-label, multi-center study with the aim of exploring the safety, tolerability, PK, and preliminary anti-tumor activity of ANS014004 as a single agent in participants with locally advanced or metastatic solid tumors.

Locally Advanced or Metastatic Solid Tumors

Avistone Biotechnology Co., Ltd.63 participantsStarted Jun 2024

San Diego, California, United States • Denver, Colorado, United States • Orlando, Florida, United States +7 more locations

A Study of Ciltacabtagene Autoleucel and Talquetamab for the Treatment of Participants With High-Risk Multiple Myeloma

A Study to Investigate ANS014004 in Participants With Locally Advanced or Metastatic Solid Tumors

Find Trials by Condition in Detroit

Phase 1b/2 Platform Study of Select Immunotherapy Combinations in Participants With Advanced Non-small Cell Lung Cancer (NSCLC)

A Study to Assess the Efficacy and Safety of Empasiprubart Versus IVIg in Adults With Multifocal Motor Neuropathy

Strength and Muscle Related Outcomes for Nutrition and Lung Function in CF

A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-associated Disease (MOG-AD)

A Study to Investigate the Safety and Efficacy of KQB548 in Participants With Advanced Solid Malignancies

Study of Erdafitinib Intravesical Delivery System for Localized Bladder Cancer

An Extension Study to Evaluate Safety and Efficacy of BMN 111 in Children With Achondroplasia

A Multi Center Study Testing a New Implant for Adults With Severe Emphysema

A Study to Evaluate Long-Term Safety, Tolerability, & Efficacy of BMN 111 in Children With Achondroplasia (ACH)

Phase 1 Study of GEN2 in Patients With Advanced Solid Tumors

Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)

Postpartum Preeclampsia Early Detection and Treatment: Nepal Pilot Study

Varenicline for Smoking Reduction in Veterans Not Ready To Quit

TITAN™ Reverse Shoulder System

A Study of Different Sequences of Cilta-cel, Talquetamab in Combination With Daratumumab and Teclistamab in Combination With Daratumumab Following Induction With Daratumumab, Bortezomib, Lenalidomide and Dexamethasone in Participants With Standard-risk Newly Diagnosed Multiple Myeloma

BGB-A3055 Alone and in Combination With Tislelizumab in Participants With Solid Tumors

Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy

A Study of JNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer